du 16 avr 2015 → 17 avr 2015 Associé à Alain Fischer, chaire Médecine expérimentale Jean-Louis Mandel, chaire Génétique humaine Documents et médias Télécharger le programme pdf (218.63 Ko) Programme Colloque Non enregistré 16 avr 2015 09:30 - 10:15 Colloque Non enregistré Emmanuelle Charpentier Genome Engineering with CRISPR-Cas9: Biology, Mechanisms and Applications in Medicine Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 10:15 - 11:00 Colloque Non enregistré Alain Fischer Gene Therapy of Primary Immunodeficiencies (PID) Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 11:00 - 11:45 Colloque Non enregistré Luigi Naldini Genetic Engineering of Human Hematopoiesis for the Treatment of Inherited Diseases and Cancer Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 14:15 - 15:00 Colloque Non enregistré Amit Nathwani Gene Therapy of Hemophilias Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 15:00 - 15:35 Colloque Non enregistré Kris de Boeck New Mutation-Specific Pharmacotherapies for Cystic Fibrosis Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 15:35 - 15:55 Colloque Non enregistré Judith Melki Added Value of New Genomics Technologies in Undiagnosed Patients Who May Benefit from Known Therapies Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 15:55 - 16:30 Colloque Non enregistré Vincent des Portes From Promising Clinical Studies to Recent Clinical Trials for the Fragile X Mental Retardation Syndrome: The Challenge of Judging Efficacy Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 17:00 - 17:35 Colloque Non enregistré Rebecca Pruss The Discovery and Development of Olesoxime for Spinal Muscular Atrophy Therapy Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 17:35 - 17:55 Colloque Non enregistré Laurence Legeai-Mallet From Gene Identification to Functional Analysis and Treatment of Achondroplasia Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 17:55 - 18:15 Colloque Non enregistré Valerie Cormier-Daire Inhibition of Thromboxane Synthase, a New Mechanism to Increase Bone Density? Novel Therapies for Monogenic Diseases Colloque Non enregistré 16 avr 2015 18:15 - 18:30 Colloque Non enregistré Xavier Nissan Selected oral communications: Drug Screening on Hutchinson Gilford Progeria Using Pluripotent Stem Cells Reveals New Pharmacological Modulators of Prelamin a Farnesylation Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 09:00 - 09:45 Colloque Non enregistré José-Alain Sahel Novel Approaches for Treatment of Retinal Diseases Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 09:45 - 10:15 Colloque Non enregistré Anna Buj Bello Gene Replacement Therapy for Myotubular Myopathy Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 10:15 - 10:35 Colloque Non enregistré Arnold Munnich REPS1 Is a Novel Gene of Neurodegeneration with Brain Iron Accumulation Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 11:00 - 11:30 Colloque Non enregistré Hélène Puccio Efficient AAV Gene Therapy in Cardiac and Neurological Murine Models for Friedreich Ataxia Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 11:30 - 11:45 Colloque Non enregistré William Lostal Selected oral communication: High Expression and Therapeutic Efficiency of Systemic Delivery of a Dual AAV Strategy in a Murine Model for Dysferlin Deficiencies Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 11:45 - 12:00 Colloque Non enregistré Nathalie Cartier Selected oral communication: Gene Therapy for Alzheimer's Disease: The Cholesterol Connection Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 12:00 - 12:45 Colloque Non enregistré Franck Dufour et Serge Braun Round table: Can We Afford Cost of Innovative Therapies for Rare Diseases? Novel Therapies for Monogenic Diseases Colloque Non enregistré 17 avr 2015 12:45 - 13:00 Colloque Non enregistré Alain Fischer Conclusions Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 09:30 - 10:15 Colloque Non enregistré Emmanuelle Charpentier Genome Engineering with CRISPR-Cas9: Biology, Mechanisms and Applications in Medicine Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 10:15 - 11:00 Colloque Non enregistré Alain Fischer Gene Therapy of Primary Immunodeficiencies (PID) Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 11:00 - 11:45 Colloque Non enregistré Luigi Naldini Genetic Engineering of Human Hematopoiesis for the Treatment of Inherited Diseases and Cancer Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 14:15 - 15:00 Colloque Non enregistré Amit Nathwani Gene Therapy of Hemophilias Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 15:00 - 15:35 Colloque Non enregistré Kris de Boeck New Mutation-Specific Pharmacotherapies for Cystic Fibrosis Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 15:35 - 15:55 Colloque Non enregistré Judith Melki Added Value of New Genomics Technologies in Undiagnosed Patients Who May Benefit from Known Therapies Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 15:55 - 16:30 Colloque Non enregistré Vincent des Portes From Promising Clinical Studies to Recent Clinical Trials for the Fragile X Mental Retardation Syndrome: The Challenge of Judging Efficacy Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 17:00 - 17:35 Colloque Non enregistré Rebecca Pruss The Discovery and Development of Olesoxime for Spinal Muscular Atrophy Therapy Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 17:35 - 17:55 Colloque Non enregistré Laurence Legeai-Mallet From Gene Identification to Functional Analysis and Treatment of Achondroplasia Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 17:55 - 18:15 Colloque Non enregistré Valerie Cormier-Daire Inhibition of Thromboxane Synthase, a New Mechanism to Increase Bone Density? Novel Therapies for Monogenic Diseases
Colloque Non enregistré 16 avr 2015 18:15 - 18:30 Colloque Non enregistré Xavier Nissan Selected oral communications: Drug Screening on Hutchinson Gilford Progeria Using Pluripotent Stem Cells Reveals New Pharmacological Modulators of Prelamin a Farnesylation Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 09:00 - 09:45 Colloque Non enregistré José-Alain Sahel Novel Approaches for Treatment of Retinal Diseases Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 09:45 - 10:15 Colloque Non enregistré Anna Buj Bello Gene Replacement Therapy for Myotubular Myopathy Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 10:15 - 10:35 Colloque Non enregistré Arnold Munnich REPS1 Is a Novel Gene of Neurodegeneration with Brain Iron Accumulation Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 11:00 - 11:30 Colloque Non enregistré Hélène Puccio Efficient AAV Gene Therapy in Cardiac and Neurological Murine Models for Friedreich Ataxia Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 11:30 - 11:45 Colloque Non enregistré William Lostal Selected oral communication: High Expression and Therapeutic Efficiency of Systemic Delivery of a Dual AAV Strategy in a Murine Model for Dysferlin Deficiencies Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 11:45 - 12:00 Colloque Non enregistré Nathalie Cartier Selected oral communication: Gene Therapy for Alzheimer's Disease: The Cholesterol Connection Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 12:00 - 12:45 Colloque Non enregistré Franck Dufour et Serge Braun Round table: Can We Afford Cost of Innovative Therapies for Rare Diseases? Novel Therapies for Monogenic Diseases
Colloque Non enregistré 17 avr 2015 12:45 - 13:00 Colloque Non enregistré Alain Fischer Conclusions Novel Therapies for Monogenic Diseases